Search research articles
Contact Us
Filters
Showing results (401-410 of 696) with videos related to
Page
of 70
Sort By:
HPB : the Official Journal of the International Hepato Pancreato Biliary Association
|
July 29, 2010
A review of factors predicting perioperative death and early outcome in hepatopancreaticobiliary cancer surgery
Chris D Mann, Tom Palser, Chris D Briggs, et al.
Scandinavian Journal of Gastroenterology
|
October 18, 2013
Influence of preformed donor-specific antibodies and C4d on early liver allograft function
M T Perera, M A Silva, N Murphy, et al.
Journal of Applied Toxicology : JAT
|
August 10, 1999
A comparison of statistical approaches to the derivation of EC3 values from local lymph node assay dose responses
D A Basketter, L J Lea, A Dickens, et al.
British Journal of Rheumatology
|
June 1, 1996
Genetic analysis of TAP2 in systemic lupus erythematosus patients from two ethnic groups
L Ocal, K Russell, H Beynon, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation
|
December 1, 1992
The diagnosis of Helicobacter pylori infection in uremic patients
P A Rowe, A M el Nujumi, C Williams, et al.
Biologicals : Journal of the International Association of Biological Standardization
|
June 25, 1998
Evaluation of the safety and immunogenicity of a new, heat-treated human rabies immune globulin using a sham, post-exposure prophylaxis of rabies
J Lang, S Gravenstein, D Briggs, et al.
American Journal of Medical Genetics
|
February 11, 1997
Multiple epiphyseal dysplasia, ribbing type: a novel point mutation in the COMP gene in a South African family
R Ballo, M D Briggs, D H Cohn, et al.
ACS Nano
|
April 9, 2009
Effects of doping on electronic structure and correlations in carbon peapods
Ling Ge, John H Jefferson, Barbara Montanari, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems
|
September 10, 2013
Metoclopramide is metabolized by CYP2D6 and is a reversible inhibitor, but not inactivator, of CYP2D6
Mara R Livezey, Erran D Briggs, Amanda K Bolles, et al.
British Medical Journal
|
March 25, 1972
Total body potassium in non-dialysed and dialysed patients with chronic renal failure
K Boddy, P C King, R M Lindsay, et al.
Page
of 70
Search research articles
Search
Showing results (401-410 of 696) with videos related to
Sort By:
Page
of 70
HPB : the Official Journal of the International Hepato Pancreato Biliary Association
|
July 29, 2010
A review of factors predicting perioperative death and early outcome in hepatopancreaticobiliary cancer surgery
Chris D Mann, Tom Palser, Chris D Briggs, et al.
Scandinavian Journal of Gastroenterology
|
October 18, 2013
Influence of preformed donor-specific antibodies and C4d on early liver allograft function
M T Perera, M A Silva, N Murphy, et al.
Journal of Applied Toxicology : JAT
|
August 10, 1999
A comparison of statistical approaches to the derivation of EC3 values from local lymph node assay dose responses
D A Basketter, L J Lea, A Dickens, et al.
British Journal of Rheumatology
|
June 1, 1996
Genetic analysis of TAP2 in systemic lupus erythematosus patients from two ethnic groups
L Ocal, K Russell, H Beynon, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation
|
December 1, 1992
The diagnosis of Helicobacter pylori infection in uremic patients
P A Rowe, A M el Nujumi, C Williams, et al.
Biologicals : Journal of the International Association of Biological Standardization
|
June 25, 1998
Evaluation of the safety and immunogenicity of a new, heat-treated human rabies immune globulin using a sham, post-exposure prophylaxis of rabies
J Lang, S Gravenstein, D Briggs, et al.
American Journal of Medical Genetics
|
February 11, 1997
Multiple epiphyseal dysplasia, ribbing type: a novel point mutation in the COMP gene in a South African family
R Ballo, M D Briggs, D H Cohn, et al.
ACS Nano
|
April 9, 2009
Effects of doping on electronic structure and correlations in carbon peapods
Ling Ge, John H Jefferson, Barbara Montanari, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems
|
September 10, 2013
Metoclopramide is metabolized by CYP2D6 and is a reversible inhibitor, but not inactivator, of CYP2D6
Mara R Livezey, Erran D Briggs, Amanda K Bolles, et al.
British Medical Journal
|
March 25, 1972
Total body potassium in non-dialysed and dialysed patients with chronic renal failure
K Boddy, P C King, R M Lindsay, et al.
Page
of 70